Chloroquine and COVID-19: A Light at the End of the Tunnel, or is it Another Train?
| dc.contributor.author | Abduzhappar Gaipov | |
| dc.contributor.author | Mohamad Aljofan | |
| dc.contributor.author | Mohamad Aljofan | |
| dc.date.accessioned | 2025-08-19T11:58:40Z | |
| dc.date.available | 2025-08-19T11:58:40Z | |
| dc.date.issued | 2020-01-01 | |
| dc.description.abstract | Over recent decades, viral outbreaks such as Hendra, Nipah, SARS, H1N1, MERS, Zika have impacted localized regions. However, COVID-19 has globally affected health systems and economies. Given its antiviral history and availability, chloroquine gained early attention as a potential COVID-19 therapeutic—yet its efficacy remains unproven. | en |
| dc.identifier.citation | Aljofan, M.; Gaipov, A. (2020). Electron Journal of General Medicine, 17(4):em207. https://doi.org/10.29333/ejgm/7863 | en |
| dc.identifier.doi | 10.29333/ejgm/7863 | |
| dc.identifier.other | Filename:Chloroquine_and_COVID-19__A_Light_at_the_End_of_the_Tunnel,_or_is_it_Another_Train___31418f41.pdf | |
| dc.identifier.uri | https://doi.org/10.29333/ejgm/7863 | |
| dc.identifier.uri | https://nur.nu.edu.kz/handle/123456789/9593 | |
| dc.language.iso | en | |
| dc.publisher | Electronic Journal of General Medicine | |
| dc.relation.ispartof | Electronic Journal of General Medicine | en |
| dc.source | Electronic Journal of General Medicine, 17(4), em207, (2020) | en |
| dc.subject | type of access: open access | en |
| dc.subject | pandemic response | en |
| dc.subject | antiviral repurposing | en |
| dc.subject | COVID-19 | en |
| dc.subject | chloroquine | en |
| dc.subject | chloroquine | en |
| dc.title | Chloroquine and COVID-19: A Light at the End of the Tunnel, or is it Another Train? | en |
| dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Chloroquine_and_COVID-19__A_Light_at_the_End_of_the_Tunnel,_or_is_it_Another_Train___31418f41.pdf
- Size:
- 106.21 KB
- Format:
- Adobe Portable Document Format